Publications by authors named "Joan Merrill"

Claim this Profile
D
Defining Optimally Safe and Effective Blood Levels of Hydroxychloroquine in Lupus: An Important Step toward Precision Drug Monitoring.
Shivani Garg, Benoît Blanchet, Yann Nguyen, Fauzia Hollnagel, Ada Clarke, Joan T Merrill

Arthritis Rheumatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality.
Yann L C Becker, Éric Boilard, Emmanuelle Rollet-Labelle, Christian Lood, Anne-Sophie Julien, Joan Merrill

Ann Rheum Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing cell therapies for lupus.
Joan T Merrill, Judith A James

Nat Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus.
Ronald F van Vollenhoven, Li Wang, Joan T Merrill, Yi Liu, Chunde Bao

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Joan T Merrill, Marie-Claude Gaudreau, Kristin M D'Silva

Arthritis Rheumatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of upadacitinib as monotherapy or combined with elsubrutinib for the treatment of systemic lupus erythematosus: results through 104 weeks in a long-term extension study.
Joan T Merrill, Amit Saxena, Martin Aringer, Yoshiya Tanaka, Xiaofeng Zeng

RMD Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: A randomized phase 2 clinical trial.
Victoria P Werth, Joan T Merrill, Richard Furie, Thomas Dörner, Ronald van Vollenhoven

J Am Acad Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease diagnostics using machine learning of B cell and T cell receptor sequences.
Maxim E Zaslavsky, Erin Craig, Jackson K Michuda, Nidhi Sehgal, Nikhil Ram-Mohan, Joan T Merrill

Science· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cenerimod, a sphingosine-1-phosphate receptor modulator, versus placebo in patients with moderate-to-severe systemic lupus erythematosus (CARE): an international, double-blind, randomised, placebo-controlled, phase 2 trial.
Anca D Askanase, David D'Cruz, Kenneth Kalunian, Joan T Merrill, Sandra V Navarra

Lancet Rheumatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled Trial.
Joan T Merrill, Yoshiya Tanaka, David D'Cruz, Karina Vila-Rivera, Daniel Siri

Arthritis Rheumatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission and low disease activity are associated with lower healthcare costs: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Megan R W Barber, Manuel Francisco Ugarte-Gil, John G Hanly, Murray B Urowitz, Yvan St-Pierre, Joan T Merrill

Ann Rheum Dis· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors associated with immune responses to SARS-CoV-2 vaccination in individuals with autoimmune diseases.
Erik Anderson, Michael Powell, Emily Yang, Ananya Kar, Tung Ming Leung, Joan Merrill

JCI Insight· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus.
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Joan T Merrill

Lupus Sci Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.
Di Wu, Jing Li, Dong Xu, Joan T Merrill, Ronald F van Vollenhoven

Ann Rheum Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial.
Joan T Merrill, Joel Guthridge, Miles Smith, Joshua June, Fotios Koumpouras

Arthritis Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception Cohort.
Yann Nguyen, Benoît Blanchet, Murray B Urowitz, John G Hanly, Caroline Gordon, Joan T Merrill

Arthritis Rheumatol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying lupus Patient Subsets Through Immune Cell Deconvolution of Gene Expression Data in Two Atacicept Phase II Studies.
Matthew Studham, Cristina Vazquez-Mateo, Eileen Samy, Philipp Haselmayer, Aida Aydemir, Joan T Merrill

ACR Open Rheumatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Costs of Neuropsychiatric Disease in the Systemic Lupus International Collaborating Clinics Cohort Using Multistate Modeling.
Ann E Clarke, John G Hanly, Murray B Urowitz, Yvan St Pierre, Caroline Gordon, Joan T Merrill

Arthritis Care Res (Hoboken)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ancestry-based differences in the immune phenotype are associated with lupus activity.
Samantha Slight-Webb, Kevin Thomas, Miles Smith, Catriona A Wagner, Susan Macwana, Joan T Merrill

JCI Insight· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes.
May Yee Choi, Irene Chen, Ann Elaine Clarke, Marvin J Fritzler, Katherine A Buhler, Joan T Merrill

Ann Rheum Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving resource utilisation in SLE drug development through innovative trial design.
Sandra Garces, Elaine Karis, Joan T Merrill, Anca D Askanase, Kenneth Kalunian

Lupus Sci Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): prespecified analysis of the phase III ustekinumab trial in patients with SLE.
Anca D Askanase, Wei Tang, Qing Zuraw, Robert Gordon, Betsy Brotherton, Joan T Merrill

Lupus Sci Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Eric Morand, Marilyn Pike, Joan T Merrill, Ronald van Vollenhoven, Victoria P Werth

Arthritis Rheumatol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort.
Manuel Francisco Ugarte-Gil, John Hanly, Murray Urowitz, Caroline Gordon, Sang-Cheol Bae, Joan T Merrill

Ann Rheum Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine.
Celline C Almeida-Brasil, John G Hanly, Murray Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Joan T Merrill

Lupus Sci Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis